Missing/wrong data?
Log in to edit
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
scientific article
Author/s
author: Hans-Peter Hartung, Howard L. Weiner, Ivana Kovářová, Eva Havrdová
Work details
Publication date
November 24, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.